Jun
2026
Shanghai New International Expo Center
Visit us
stand E3A42, Finished Dosage

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (NKF), headquartered in Nanjing, China, is a leading global biopharmaceutical enterprise dedicated to building an integrated platform for internationalization of its high-end injectables and to serve domestic pharmaceutical manufacturers in expanding their business around the globe. With over a dozen of ANDAs approved in US each year, NKF has grown into one of the biggest suppliers of high-end injectables in the US. NKF is also one of the biggest suppliers of Heparin APIs and finished dosage forms, and is actively working with partners from over 60 countries for over 80 USFDA approved products.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • (86-25) 86990701
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3A42, Finished Dosage

Products Featured at CPHI & PMEC China 2026

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.